1002 Merck Perlmutter
BioCentury & Getty Images

Management Tracks

Li to guide Merck’s next wave of cancer therapies launched by Perlmutter

Oct 3, 2020 | 3:16 AM GMT

Dean Li will take over a Merck Research Laboratories that has been transformed by Roger Perlmutter over the past seven years, guiding a pharma that had been struggling with a patent cliff to the company that churns out approval after approval

Read the full 667 word article

How to gain access

Continue reading with a
two-week free trial.